ALLMedicine™ Beta2-microglobulin Center
Research & Reviews 221 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7259768
PloS One; Colussi G, Brunati CCM et. al.
May 29th, 2020 - Dialysis urea removal metrics may not translate into proportional removal efficiency of non-urea solutes. We show that the Kt factor (plasma volume totally cleared of any solutes) differentiates removal efficiency of non-urea solutes in different ...
https://emedicine.medscape.com/article/203399-workup
Jun 11th, 2019 - Approach Considerations The workup in a patient with suspected non-Hodgkin lymphoma (NHL) should include the following: Complete blood cell (CBC) count Serum chemistry studies, including lactate dehydrogenase (LDH) Serum beta2-microglobulin level ...
https://doi.org/10.1080/10428194.2019.1594212
Leukemia & Lymphoma; Sorigue M, Bishton M et. al.
Apr 3rd, 2019 - Short responses to immunochemotherapy predict for an inferior OS in follicular lymphoma. We set out to determine whether this is also the case in marginal zone lymphoma. A group of 139 marginal zone lymphoma (MZL) patients treated with front-line ...
https://doi.org/10.1159/000495022
Blood Purification; Leypoldt JK, Prichard S et. al.
Jan 30th, 2019 - High dialysate flow rates (QD) of 500-800 mL/min are used to maximize urea removal during conventional hemodialysis. There are few data describing hemodialysis with use of mid-rate QD (300 mL/min). We constructed uremic solute (urea, beta2-microgl...
https://clinicaltrials.gov/ct2/show/NCT02863016
Aug 30th, 2018 - The primary objective of this study was to evaluate if a hemodiafiltration with concentrated citrate (Cit-HDF) in 3 months can reduce the inflammation markers, evaluated by a Predialytic value of Beta2-microglobulin (B2m), CRP and IL6 compared to ...
Clinicaltrials.gov 221 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7259768
PloS One; Colussi G, Brunati CCM et. al.
May 29th, 2020 - Dialysis urea removal metrics may not translate into proportional removal efficiency of non-urea solutes. We show that the Kt factor (plasma volume totally cleared of any solutes) differentiates removal efficiency of non-urea solutes in different ...
https://emedicine.medscape.com/article/203399-workup
Jun 11th, 2019 - Approach Considerations The workup in a patient with suspected non-Hodgkin lymphoma (NHL) should include the following: Complete blood cell (CBC) count Serum chemistry studies, including lactate dehydrogenase (LDH) Serum beta2-microglobulin level ...
https://doi.org/10.1080/10428194.2019.1594212
Leukemia & Lymphoma; Sorigue M, Bishton M et. al.
Apr 3rd, 2019 - Short responses to immunochemotherapy predict for an inferior OS in follicular lymphoma. We set out to determine whether this is also the case in marginal zone lymphoma. A group of 139 marginal zone lymphoma (MZL) patients treated with front-line ...
https://doi.org/10.1159/000495022
Blood Purification; Leypoldt JK, Prichard S et. al.
Jan 30th, 2019 - High dialysate flow rates (QD) of 500-800 mL/min are used to maximize urea removal during conventional hemodialysis. There are few data describing hemodialysis with use of mid-rate QD (300 mL/min). We constructed uremic solute (urea, beta2-microgl...
https://clinicaltrials.gov/ct2/show/NCT02863016
Aug 30th, 2018 - The primary objective of this study was to evaluate if a hemodiafiltration with concentrated citrate (Cit-HDF) in 3 months can reduce the inflammation markers, evaluated by a Predialytic value of Beta2-microglobulin (B2m), CRP and IL6 compared to ...
News 1 results
https://www.mdedge.com/ccjm/article/93315/beta2-microglobulin-amyloidosis-renal-failure-understanding-recently-recognized
Jonathan Kay, MD
ABSTRACT Beta2-microglobulin amyloidosis can cause significant suffering in patients with chronic renal failure. Although renal transplantation is currently the only treatment, medical and surgical therapies may decrease pain and disability.
